Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends approval of Jetrea in Europe for vitreomacular traction

Jan. 21, 2013

Bosutinib receives positive CHMP opinion for conditional marketing authorization

Jan. 21, 2013

European CHMP set to discuss MAA for defibrotide

Jan. 18, 2013

European CHMP hands down negative opinion for Raxone MAA

Jan. 18, 2013

FDA and EMA to review GE Healthcare's applications for flutemetamol (18F)

Jan. 10, 2013

European orphan drug designation recommended for VAL-083 for glioma

Jan. 8, 2013

EMA accepts MAA for aripiprazole depot formulation

Dec. 24, 2012

Intercell obtains positive CHMP opinion for pediatric use of its JE vaccine

Dec. 20, 2012

Roche's Perjeta receives CHMP recommendation for approval

Dec. 18, 2012

Alexza's MAA for Adasuve receives positive opinion from EMA advisory committee

Dec. 18, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...